Completed NA INTERVENTIONAL 2-arm NCT04399746

Ivermectin-Azithromycin-Cholecalciferol (IvAzCol) Combination Therapy for COVID-19 (IvAzCol)

A Pilot Study for COVID-19 Outpatient Treatment With the Combination of Ivermectin-azithromycin-cholecalciferol

Sponsor: Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado

Conditions COVID

Interventions Azithromycin Cholecalciferol Ivermectin

Updated 5 times since 2020 Last updated: Mar 9, 2022 Started: Mar 15, 2020 Primary completion: May 20, 2020 Completion: Jun 10, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates COVID and is currently completed. Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado leads this study, which shows 5 recorded versions since 2020 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Apr 2022 — Jul 2024 [monthly]

Completed NA

Status: Recruiting → Completed
Jan 2021 — Apr 2022 [monthly]

Recruiting NA
Jun 2020 — Jan 2021 [monthly]

Recruiting NA

First recorded

Mar 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado

Data source: Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Mexico City, Mexico